Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
4 search results for:

387 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 21-07-2022 | Breast cancer | News | Article

    KEYNOTE-355 shows OS benefit with pembrolizumab–chemo in advanced TNBC

    . © 2022 Springer Healthcare Ltd, part of the Springer Nature Group N Engl J Med 2022; 387 : 217–226 N Engl J Med 2022; 387 : 273–274

    Author:
    Shreeya Nanda
    Published in:
    N Engl J Med 2022; 387 : 217–226 N Engl J Med 2022; 387 : 273–274
  2. 01-12-2021 | Breast cancer | News | Article

    UK PROSPER trial backs early exercise after breast cancer surgery

    However, when all healthcare and personal social services costs were taken into account the intervention was associated with an average cost saving of £ 387 ($ 516; € 457) per participant.

    Author:
    Laura Cowen
    Published in:
    BMJ 2021; 375 : e066542
  3. 04-07-2016 | Multiple myeloma | Article

    Lifestyle in multiple myeloma - a longitudinal cohort study protocol

    Heinrich et al. discuss a prospective cohort study of multiple myeloma patients in remission to identify the point at which physical activity interventions may be introduced for maximum benefit. Heinrich M et al. BMC Cancer 2016; 16: 387. doi:10.1186/s12885-016-2407-x

  4. 18-10-2016 | Bcr-Abl tyrosine kinase inhibitors | ReviewPaper | Article

    Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

    Dasatinib was tested at a dose of 70 mg b.i.d. as second-line treatment in a single-arm phase II study of 387 patients with imatinib resistance (74%) or intolerance (26%) 106, 107 .

    Author:
    Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, Michele Baccarani
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.